A Study to Evaluate Efficacy and Safety of Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) Fixed Dose Combination (FDC) Versus a Regimen Consisting of Darunavir/Cobicistat FDC With Emtricitabine/Tenofovir Disoproxil Fumarate FDC in Treatment-naive HIV Type 1 Infected Subjects By midwayadmin|2019-10-28T19:29:04+00:00October 28th, 2019| Read More
Safety and Efficacy of Bictegravir/Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir + Emtricitabine/Tenofovir Alafenamide in HIV-1 Infected, Antiretroviral Treatment-Naive Adults By midwayadmin|2019-10-28T19:27:18+00:00October 28th, 2019| Read More
Safety and Efficacy of Bictegravir/Emtricitabine/Tenofovir Alafenamide Versus Abacavir/Dolutegravir/Lamivudine in HIV-1 Infected, Antiretroviral Treatment-Naïve Adults By midwayadmin|2019-10-28T19:25:36+00:00October 28th, 2019| Read More
An Efficacy, Safety, and Tolerability Study Comparing Dolutegravir (DTG) Plus Lamivudine (3TC) With Dolutegravir Plus Tenofovir/Emtricitabine in Treatment naïve HIV Infected Subjects (Gemini 2) By midwayadmin|2019-10-28T19:22:32+00:00October 28th, 2019| Read More
An Efficacy, Safety, and Tolerability Study Comparing Dolutegravir Plus Lamivudine With Dolutegravir Plus Tenofovir/Emtricitabine in Treatment naïve HIV Infected Subjects (Gemini 1) By midwayadmin|2019-10-28T19:21:40+00:00October 28th, 2019| Read More
Study Evaluating the Efficacy, Safety, and Tolerability of Switching to Long-acting Cabotegravir Plus Long-acting Rilpivirine From Current Antiretroviral Regimen in Virologically Suppressed HIV-1-infected Adults By midwayadmin|2019-10-28T19:20:19+00:00October 28th, 2019| Read More
Study of PRO 140 SC as Single Agent Maintenance Therapy in Virally Suppressed Subjects With CCR5-tropic HIV-1 Infection By midwayadmin|2019-10-28T19:19:06+00:00October 28th, 2019| Read More
Safety and Efficacy of Emtricitabine and Tenofovir Alafenamide (F/TAF) Fixed-Dose Combination Once Daily for Pre-Exposure Prophylaxis in Men and Transgender Women Who Have Sex With Men and Are At Risk of HIV-1 Infection (DISCOVER) By midwayadmin|2019-10-28T19:17:35+00:00October 28th, 2019| Read More
B/F/TAF FDC in HIV-1 Infected Virologically Suppressed Adolescents and Children By midwayadmin|2019-10-28T19:16:32+00:00October 28th, 2019| Read More
Switching to a Fixed Dose Combination of Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) in HIV-1 Infected Adults Who Are Virologically Suppressed By midwayadmin|2019-10-28T19:15:17+00:00October 28th, 2019| Read More
